These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Tissue specificity drives protective immunity against Beesetty P; Si Y; Li Z; Yang C; Zhao F; Chong AS; Montgomery CP Front Immunol; 2022; 13():795792. PubMed ID: 35983063 [TBL] [Abstract][Full Text] [Related]
5. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections. Adhikari RP; Thompson CD; Aman MJ; Lee JC Vaccine; 2016 Dec; 34(50):6402-6407. PubMed ID: 27847174 [TBL] [Abstract][Full Text] [Related]
6. Role of antibodies in protection elicited by active vaccination with genetically inactivated alpha hemolysin in a mouse model of staphylococcus aureus skin and soft tissue infections. Mocca CP; Brady RA; Burns DL Clin Vaccine Immunol; 2014 May; 21(5):622-7. PubMed ID: 24574539 [TBL] [Abstract][Full Text] [Related]
7. Interleukin-10 (IL-10) Produced by Mutant Toxic Shock Syndrome Toxin 1 Vaccine-Induced Memory T Cells Downregulates IL-17 Production and Abrogates the Protective Effect against Staphylococcus aureus Infection. Narita K; Hu DL; Asano K; Nakane A Infect Immun; 2019 Oct; 87(10):. PubMed ID: 31358568 [TBL] [Abstract][Full Text] [Related]
8. A serologic correlate of protective immunity against community-onset Staphylococcus aureus infection. Fritz SA; Tiemann KM; Hogan PG; Epplin EK; Rodriguez M; Al-Zubeidi DN; Bubeck Wardenburg J; Hunstad DA Clin Infect Dis; 2013 Jun; 56(11):1554-61. PubMed ID: 23446627 [TBL] [Abstract][Full Text] [Related]
9. Protection against Staphylococcus aureus Colonization and Infection by B- and T-Cell-Mediated Mechanisms. Zhang F; Ledue O; Jun M; Goulart C; Malley R; Lu YJ mBio; 2018 Oct; 9(5):. PubMed ID: 30327437 [No Abstract] [Full Text] [Related]
10. Toxin expression during Staphylococcus aureus infection imprints host immunity to inhibit vaccine efficacy. Teymournejad O; Li Z; Beesetty P; Yang C; Montgomery CP NPJ Vaccines; 2023 Jan; 8(1):3. PubMed ID: 36693884 [TBL] [Abstract][Full Text] [Related]
11. Toxic Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model of Staphylococcal Soft Tissue Infection. Sharma H; Turner CE; Siggins MK; El-Bahrawy M; Pichon B; Kearns A; Sriskandan S mSphere; 2019 Oct; 4(5):. PubMed ID: 31597722 [TBL] [Abstract][Full Text] [Related]
12. Targeting Staphylococcus aureus α-toxin as a novel approach to reduce severity of recurrent skin and soft-tissue infections. Sampedro GR; DeDent AC; Becker RE; Berube BJ; Gebhardt MJ; Cao H; Bubeck Wardenburg J J Infect Dis; 2014 Oct; 210(7):1012-8. PubMed ID: 24740631 [TBL] [Abstract][Full Text] [Related]
13. Host factors that contribute to recurrent staphylococcal skin infection. Montgomery CP; David MZ; Daum RS Curr Opin Infect Dis; 2015 Jun; 28(3):253-8. PubMed ID: 25887613 [TBL] [Abstract][Full Text] [Related]
14. IL-17A plays an important role in protection induced by vaccination with fibronectin-binding domain of fibronectin-binding protein A against Staphylococcus aureus infection. Narita K; Asano K; Nakane A Med Microbiol Immunol; 2017 Jun; 206(3):225-234. PubMed ID: 28378247 [TBL] [Abstract][Full Text] [Related]
15. Mechanism of action and in vivo efficacy of a human-derived antibody against Staphylococcus aureus α-hemolysin. Foletti D; Strop P; Shaughnessy L; Hasa-Moreno A; Casas MG; Russell M; Bee C; Wu S; Pham A; Zeng Z; Pons J; Rajpal A; Shelton D J Mol Biol; 2013 May; 425(10):1641-54. PubMed ID: 23416200 [TBL] [Abstract][Full Text] [Related]
16. Vaccination with non-toxic mutant toxic shock syndrome toxin-1 induces IL-17-dependent protection against Staphylococcus aureus infection. Narita K; Hu DL; Asano K; Nakane A Pathog Dis; 2015 Jun; 73(4):. PubMed ID: 25857736 [TBL] [Abstract][Full Text] [Related]
17. Active Immunization with Extracellular Vesicles Derived from Staphylococcus aureus Effectively Protects against Staphylococcal Lung Infections, Mainly via Th1 Cell-Mediated Immunity. Choi SJ; Kim MH; Jeon J; Kim OY; Choi Y; Seo J; Hong SW; Lee WH; Jeon SG; Gho YS; Jee YK; Kim YK PLoS One; 2015; 10(9):e0136021. PubMed ID: 26333035 [TBL] [Abstract][Full Text] [Related]
18. Impaired T-Lymphocyte Responses During Childhood Staphylococcus aureus Infection. Li Z; Beesetty P; Gerges G; Kleinhenz M; Moore-Clingenpeel M; Yang C; Ahmed LB; Hensley J; Steele L; Chong AS; Montgomery CP J Infect Dis; 2022 Jan; 225(1):177-185. PubMed ID: 34145461 [TBL] [Abstract][Full Text] [Related]
19. Novel structurally designed vaccine for S. aureus α-hemolysin: protection against bacteremia and pneumonia. Adhikari RP; Karauzum H; Sarwar J; Abaandou L; Mahmoudieh M; Boroun AR; Vu H; Nguyen T; Devi VS; Shulenin S; Warfield KL; Aman MJ PLoS One; 2012; 7(6):e38567. PubMed ID: 22701668 [TBL] [Abstract][Full Text] [Related]